Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

DSpace/Manakin Repository

Show simple item record

dc.creator Perroud, Herman A
dc.creator Scharovsky, O. Graciela
dc.creator Rozados, Viviana R.
dc.creator Alasino, Carlos María
dc.date.accessioned 2018-07-02T15:36:08Z
dc.date.available 2018-07-02T15:36:08Z
dc.date.issued 2017-02-28
dc.identifier.issn 1754-6605 es
dc.identifier.uri http://hdl.handle.net/2133/11512
dc.description Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, doses of chemotherapeutic drugs with therapeutic efficacy and low toxicity. This is an effective and low-cost way to treat several types of tumours, including ovarian cancer. Here, we present six cases of advanced ovarian cancer treated with MCT with low doses of cyclophosphamide, which showed clinical response and stable disease. es
dc.description.sponsorship Fundación Roemmers es
dc.description.sponsorship Ministerio de Ciencia, Tecnología e Innovación de Santa Fe, Argentina. es
dc.format application/pdf
dc.format.extent 1-10 es
dc.language.iso eng es
dc.publisher Cancer Intelligence es
dc.rights openAccess es
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/2.5/ar/ *
dc.subject ovarian cancer es
dc.subject metronomic chemotherapy es
dc.subject cyclophosphamide es
dc.title Clinical response in patients with ovarian cancer treated with metronomic chemotherapy es
dc.type article
dc.type artículo
dc.type publishedVersion
dc.rights.holder Perroud et al.; licensee PubMed Central es
dc.rights.holder © the authors; licensee ecancermedicalscience es
dc.relation.publisherversion https://doi.org/10.3332/ecancer.2017.723 es
dc.rights.text This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. es
dc.citation.title ecancermedicalscience es
dc.citation.volume 11 es
dc.description.fil Fil: Perroud, Herman A. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; Argentina es
dc.description.fil Fil: Scharovsky, Graciela Olga. Universidad Nacional de Rosario. Consejo de Investigaciones UNR, Facultad de Ciencias Médicas; Argentina es
dc.description.fil Fil: Rozados, Viviana R. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; Argentina es
dc.description.fil Fil: Alasino, Carlos María. Institute of Oncology of Rosario; Argentina es
dc.type.collection articulo
dc.type.version publishedVersion es


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

openAccess Except where otherwise noted, this item's license is described as openAccess

My Account


Search DSpace


Browse

Statistics